NCT07592195

Brief Summary

This study aims to investigate the effects of an 8-week combined exercise program on male individuals in drug rehabilitation. The program integrates resistance-based breathing training with aerobic exercise. The investigators seek to determine whether this combined exercise program is more effective than a single form of exercise in improving participants' physical health and quality of life. The primary research questions to be addressed include: Does this combined exercise program produce better results than single-form training (resistance-based breathing training or aerobic exercise performed separately) in improving physiological indicators such as cardiopulmonary function and muscle strength in male individuals in drug rehabilitation? Does this combined exercise program yield greater benefits than single-form training in reducing anxiety and depression and improving quality of life among men in drug rehabilitation? This study will conduct a randomized controlled trial. Researchers will compare three different intervention groups-the combined training group, the resistance-breathing training group, and the aerobic exercise group-to verify the potential advantages of the combined program over single-form exercise. Participants will: Complete an 8-week exercise intervention, consisting of three sessions per week, each lasting approximately 40 minutes, under professional guidance and supervision. Undergo comprehensive assessments before and after the intervention, including cardiopulmonary function tests, body composition analysis, and questionnaires on mental health and quality of life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
0mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Apr 2026Jun 2026

Study Start

First participant enrolled

April 1, 2026

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

April 28, 2026

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 18, 2026

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2026

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

May 18, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 28, 2026

Last Update Submit

May 11, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Quality of Life Scale for Drug Addicts

    Minimum score: 41, Maximum score: 205.Higher scores indicate worse quality of life and more severe impairment in physical, psychological, social, and withdrawal-related symptoms.

    Baseline (Week 0), after the intervention (Week 9)

  • 6-Minute Walk Test

    The maximum distance a subject can cover in 6 minutes while walking at maximum speed along a 30-meter flat corridor. This test is used to assess cardiopulmonary function and exercise endurance during submaximal exercise.

    Baseline (Week 0), after the intervention (Week 9)

Secondary Outcomes (4)

  • BMI

    Baseline (Week 0), after the intervention (Week 9)

  • Body Composition

    Baseline (Week 0), after the intervention (Week 9)

  • Symptom Checklist-90

    Baseline (Week 0), after the intervention (Week 9)

  • Vital Capacity

    Baseline (Week 0), after the intervention (Week 9)

Other Outcomes (8)

  • Blood pressure

    Baseline (Week 0), after the intervention (Week 9)

  • Oxygen Saturation

    Baseline (Week 0), after the intervention (Week 9)

  • Resting heart rate

    Baseline (Week 0), after the intervention (Week 9)

  • +5 more other outcomes

Study Arms (3)

Resistance Breathing Training Group

EXPERIMENTAL

Use a resistance breathing trainer and follow a progressive resistance training regimen, starting with low resistance and gradually increasing the intensity based on individual tolerance.

Device: Resistance Breathing Training

Aerobic Exercise Group

EXPERIMENTAL

This session features moderate-intensity aerobic exercise, with intensity maintained at 60-70% of maximum heart rate, and includes a warm-up, main workout, and cool-down.

Behavioral: Aerobic Exercise

Joint Training Group

EXPERIMENTAL

After the warm-up, start with 15 minutes of resistance breathing exercises, followed by 15 minutes of aerobic exercise, and then five minutes of stretching.

Device: Resistance Breathing TrainingBehavioral: Aerobic Exercise

Interventions

Warm-up (5 minutes) → Threshold resistance breathing trainer (30 minutes) → Cool-down stretches (5 minutes).During joint training, each session lasts 15 minutes.

Also known as: Three-Ball Breathing Trainer, Patent Number:2021212828371
Joint Training GroupResistance Breathing Training Group

Warm-up (5 minutes) → Main exercise (30 minutes, at 65%-85% of maximum heart rate or a Borg RPE score of 12-14) → Cool-down and stretching (5 minutes).During joint training sessions, each training session lasts 15 minutes.

Also known as: Audio
Aerobic Exercise GroupJoint Training Group

Eligibility Criteria

Age18 Years - 50 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male, aged 18 to 50 years, able to understand and comply with the study protocol
  • Meets the DSM-5 diagnostic criteria for substance use disorder; in rehabilitation for ≥1 month; withdrawal symptoms are stable (confirmed by medical staff)
  • No severe cardiovascular/cerebrovascular disease, respiratory disease, musculoskeletal injury, or other contraindications to physical activity
  • Basic reading and writing ability to independently complete questionnaire assessments
  • Voluntarily signed informed consent and committed to complying with the 8-week training program

You may not qualify if:

  • Presence of contraindications to exercise (e.g., recent fracture, severe arrhythmia, uncontrolled hypertension)
  • Concurrent severe mental disorders (e.g., schizophrenia, acute depressive episode) or currently receiving unstable psychiatric medication
  • Currently participating in other intervention studies or clinical trials
  • Expected training compliance rate \<70% (e.g., unable to complete the 8-week intervention due to transfer or disciplinary action)
  • Unable to continue participation for personal reasons (e.g., early discharge, serious disciplinary violation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yongtingli

Luzhou, 646000, China

RECRUITING

MeSH Terms

Conditions

Substance-Related Disorders

Interventions

Exercise

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Graduate student

Study Record Dates

First Submitted

April 28, 2026

First Posted

May 18, 2026

Study Start

April 1, 2026

Primary Completion

June 10, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

May 18, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations